US › Healthcare

Annexon Inc (ANNX)

US · Healthcare · Biotechnology

$5.33+1.52%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-44.1M

Profit YoY

+18.8%

EPS

$-0.23

EPS estimate

$-0.30

EPS came in at -0.23 against a street estimate of -0.30 — a beat of 23.3%.

Key statistics

Market cap

$860.2M

Forward P/E

0.0

P/B

4.09

Book value

$1.26

EPS (TTM)

$-1.20

52-week high

$7.18

52-week low

$2.03

50-day MA

$5.36

200-day MA

$5.13

Beta

1.22

Analyst view

Analysts rate Annexon Inc a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $13.56.

Shareholding

Insiders

0.49%

Institutions

102.50%

Largest institutional holders

Fund	Stake
Redmile Group, LLC	8.88%
BlackRock Inc	6.68%
FMR Inc	6.49%
Bvf Inc	5.31%
Vanguard Group Inc	4.73%
State Street Corp	4.22%
Vanguard Capital Management, LLC	3.64%
Bain Capital Life Sciences Investors, LLC	3.18%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Annexon Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.